Advertisement

Topics

Regeneron and bluebird bio enter cell therapy pact

15:40 EDT 10 Aug 2018 | Elsevier Business Intelligence

Regeneron Pharmaceuticals Inc. and bluebird bio Inc. will lean on each other’s platform discoveries to together discover an...

Original Article: Regeneron and bluebird bio enter cell therapy pact

NEXT ARTICLE

More From BioPortfolio on "Regeneron and bluebird bio enter cell therapy pact"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...